Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
The National Cancer Institute and the pharmaceutical maker Allergan Inc. are jointly supporting a trial to determine whether bimatoprost (Latisse) can stimulate regrowth of eyelashes and eyebrows after their loss in chemotherapy.
Latisse lash lengthener has its fans and detractors
Many users swear by its effectiveness, but the drug, developed to treat glaucoma, can have unpleasant side effects.
View original post here:
Latisse lash lengthener has its fans and detractors
